Sargent Investment Group, LLC Ardelyx, Inc. Transaction History

Sargent Investment Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$3.29 - $6.64 $53,028 - $107,023	-16,118 Reduced 44.85%	19,819 $122,000
Q2 2023 Jul 31, 2023	BUY	$3.23 - $4.95 $6,414 - $9,830	1,986 Added 5.85%	35,937 $121,000
Q1 2023 May 02, 2023	BUY	$2.68 - $4.79 $30,734 - $54,931	11,468 Added 51.01%	33,951 $162,000
Q4 2022 Jan 31, 2023	SELL	$1.22 - $2.85 $43,464 - $101,536	-35,627 Reduced 61.31%	22,483 $64,000
Q3 2022 Oct 26, 2022	BUY	$0.59 - $1.44 $34,284 - $83,678	58,110 New	58,110 $94,000
Q4 2021 Feb 11, 2022	SELL	$0.86 - $1.7 $9,240 - $18,266	-10,745 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.27 - $8.17 $13,646 - $87,786	10,745 New	10,745 $14,000
Q2 2021 Aug 05, 2021	SELL	$6.55 - $8.98 $66,836 - $91,631	-10,204 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$6.1 - $7.69 $164 - $207	27 Added 0.27%	10,204 $68,000
Q4 2020 Feb 10, 2021	BUY	$5.05 - $7.1 $51,393 - $72,256	10,177 New	10,177 $66,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Investment Group, LLC with notifications on news.